{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T22:33:27Z","timestamp":1722033207618},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"31","license":[{"start":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"Italian Ministry of Health","award":["RF-2013-02356787","NET-2011-02347173"],"award-info":[{"award-number":["RF-2013-02356787","NET-2011-02347173"]}]},{"name":"Telethon Italy","award":["GGP13162"],"award-info":[{"award-number":["GGP13162"]}]},{"name":"ToRSADE"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,14]]},"DOI":"10.1093\/eurheartj\/ehy297","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T03:16:55Z","timestamp":1529032615000},"page":"2908-2910","source":"Crossref","is-referenced-by-count":8,"title":["Channelopathies, cardiac hypertrophy, and the theory of light"],"prefix":"10.1093","volume":"39","author":[{"given":"Iacopo","family":"Olivotto","sequence":"first","affiliation":[{"name":"Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Coppini","sequence":"additional","affiliation":[{"name":"Department NeuroFarBa, University of Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"key":"key\n\t\t\t\t20180820094405_ehy297-B1","volume-title":"Einstein: His Life and Universe","author":"Isaacson","year":"2008"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B2","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/eurheartj\/ehy247","article-title":"A common co-morbidity modulates disease expression and treatment efficacy in inherited cardiac sodium channelopathy","volume":"39","author":"Rivaud","year":"2018","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B3","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/CIRCULATIONAHA.114.013773","article-title":"Progression of electroanatomic substrate and electric storm recurrence in a patient with Brugada syndrome","volume":"131","author":"Notarstefano","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B5","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2016.07.779","article-title":"Patient-specific and genome-edited induced pluripotent stem cell-derived cardiomyocytes elucidate single-cell phenotype of Brugada syndrome","volume":"68","author":"Liang","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.113.003077","article-title":"Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype","volume":"129","author":"Cerrone","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","article-title":"Sodium channel mutations and susceptibility to heart failure and atrial fibrillation","volume":"293","author":"Olson","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI84669","article-title":"Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice","volume":"126","author":"Wan","year":"2016","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cvr\/cvs219","article-title":"Intercalated disc abnormalities, reduced Na+ current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes","volume":"95","author":"Rizzo","year":"2012","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cvr\/cvs218","article-title":"Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency","volume":"95","author":"Cerrone","year":"2012","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B11","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/01.CIR.98.23.2545","article-title":"Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes","volume":"98","author":"Maltsev","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/CIRCULATIONAHA.114.015218","article-title":"Voltage-gated sodium channel phosphorylation at Ser571 regulates late current, arrhythmia, and cardiac function in vivo","volume":"132","author":"Glynn","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B14","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14223","article-title":"Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium","author":"Ferrantini","year":"2018","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20180820094405_ehy297-B15","doi-asserted-by":"crossref","first-page":"e004124","DOI":"10.1161\/CIRCHEARTFAILURE.117.004124","article-title":"Efficacy of ranolazine in patients with symptomatic hypertrophic cardiomyopathy: the RESTYLE-HCM randomized, double-blind, placebo-controlled study","volume":"11","author":"Olivotto","year":"2018","journal-title":"Circ Heart Fail"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/39\/31\/2908\/25515589\/ehy297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T13:14:33Z","timestamp":1571490873000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/39\/31\/2908\/5042200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":15,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2018,6,21]]},"published-print":{"date-parts":[[2018,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehy297","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8,14]]},"published":{"date-parts":[[2018,6,21]]}}}